An RSV Live-Attenuated Vaccine Candidate Lacking G Protein Mucin Domains Is Attenuated, Immunogenic, and Effective in Preventing RSV in BALB/c Mice
暂无分享,去创建一个
S. Lapp | A. Piantadosi | He-ying Sun | M. Moore | C. Rostad | Christopher C. Stobart | Xuemin Chen | E. Anderson | T. Snider | S. Jadhao | Bo Liang | Michael Koval | L. Anderson | Azmain Taz | Hui-mien Hsiao | Molly K Roe | M. Perez | Audrey R. Young | Yara S Batista | Ryan C Reed | Audrey R Young | M. A. Perez
[1] S. Madhi,et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis , 2022, The Lancet.
[2] Michael Koval,et al. A medium composition containing normal resting glucose that supports differentiation of primary human airway cells , 2022, Scientific Reports.
[3] Oriol Vinyals,et al. Highly accurate protein structure prediction with AlphaFold , 2021, Nature.
[4] J. Avner,et al. Delayed Seasonal RSV Surge Observed During the COVID-19 Pandemic , 2021, Pediatrics.
[5] M. van Boven,et al. Population-based serology reveals risk factors for RSV infection in children younger than 5 years , 2021, Scientific Reports.
[6] O. Ramilo,et al. The larger attachment glycoprotein of respiratory syncytial virus produced in primary human bronchial epithelial cultures reduces infectivity for cell lines , 2021, PLoS pathogens.
[7] S. Delagrave,et al. Evaluation of the respiratory syncytial virus G-directed neutralizing antibody response in the human airway epithelial cell model. , 2020, Virology.
[8] Puneet Juneja,et al. Cryo-EM structure of the respiratory syncytial virus RNA polymerase , 2020, Nature Communications.
[9] W. Martinet,et al. Characterization of the role of N-glycosylation sites in the respiratory syncytial virus fusion protein in virus replication, syncytium formation and antigenicity. , 2019, Virus research.
[10] Christopher C. Stobart,et al. A Contemporary View of Respiratory Syncytial Virus (RSV) Biology and Strain-Specific Differences , 2019, Pathogens.
[11] M. Moore,et al. Enhancing the Thermostability and Immunogenicity of a Respiratory Syncytial Virus (RSV) Live-Attenuated Vaccine by Incorporating Unique RSV Line19F Protein Residues , 2017, Journal of Virology.
[12] L. Kauvar,et al. Respiratory Syncytial Virus: Targeting the G Protein Provides a New Approach for an Old Problem , 2017, Journal of Virology.
[13] B. Graham,et al. A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation , 2016, Nature Communications.
[14] B. Graham,et al. A Recombinant Respiratory Syncytial Virus Vaccine Candidate Attenuated by a Low-Fusion F Protein Is Immunogenic and Protective against Challenge in Cotton Rats , 2016, Journal of Virology.
[15] M. Moore,et al. Reverse Genetics of Respiratory Syncytial Virus. , 2016, Methods in molecular biology.
[16] Michael J E Sternberg,et al. The Phyre2 web portal for protein modeling, prediction and analysis , 2015, Nature Protocols.
[17] R. Plemper,et al. Identification of Residues in the Human Respiratory Syncytial Virus Fusion Protein That Modulate Fusion Activity and Pathogenesis , 2014, Journal of Virology.
[18] Kartik Chandran,et al. Comprehensive Functional Analysis of N-Linked Glycans on Ebola Virus GP1 , 2014, mBio.
[19] J. McLellan,et al. Structure and function of respiratory syncytial virus surface glycoproteins. , 2013, Current topics in microbiology and immunology.
[20] R. Plemper,et al. A stabilized respiratory syncytial virus reverse genetics system amenable to recombination-mediated mutagenesis. , 2012, Virology.
[21] P. Bates,et al. Steric Shielding of Surface Epitopes and Impaired Immune Recognition Induced by the Ebola Virus Glycoprotein , 2010, PLoS pathogens.
[22] B. Murphy,et al. The Secreted Form of Respiratory Syncytial Virus G Glycoprotein Helps the Virus Evade Antibody-Mediated Restriction of Replication by Acting as an Antigen Decoy and through Effects on Fc Receptor-Bearing Leukocytes , 2008, Journal of Virology.
[23] R. Karron,et al. The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines. , 2007, Vaccine.
[24] P. Wright,et al. Growth of Respiratory Syncytial Virus in Primary Epithelial Cells from the Human Respiratory Tract , 2005, Journal of Virology.
[25] R. Chanock,et al. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. , 1969, American journal of epidemiology.